Cullen/Frost Bankers, Inc. Abb Vie Inc. Transaction History

Cullen/Frost Bankers, Inc.

$7.23 Billion
Q3 2024

A detailed history of Cullen/Frost Bankers, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Cullen/Frost Bankers, Inc. holds 402,104 shares of ABBV stock, worth $72.4 Million. This represents 1.1% of its overall portfolio holdings.

Number of Shares

402,104

Previous 397,811 1.08%

Holding current value

$72.4 Million

Previous $68.2 Million 16.38%

% of portfolio

1.1%

Previous 1.0%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 06, 2024	BUY	$163.84 - $199.33 $703,365 - $855,723	4,293 Added 1.08%	402,104 $79.4 Million
Q2 2024 Aug 05, 2024	BUY	$154.79 - $180.76 $4.68 Million - $5.47 Million	30,259 Added 8.23%	397,811 $68.2 Million
Q1 2024 May 10, 2024	BUY	$159.82 - $182.1 $1.25 Million - $1.43 Million	7,848 Added 2.18%	367,552 $66.9 Million
Q4 2023 Feb 06, 2024	BUY	$137.6 - $154.97 $4.82 Million - $5.43 Million	35,053 Added 10.8%	359,704 $55.7 Million
Q3 2023 Nov 02, 2023	BUY	$133.59 - $154.65 $289,355 - $334,971	2,166 Added 0.67%	324,651 $48.4 Million
Q2 2023 Aug 04, 2023	SELL	$132.51 - $164.9 $570,853 - $710,389	-4,308 Reduced 1.32%	322,485 $43.4 Million
Q1 2023 May 05, 2023	BUY	$144.61 - $166.54 $1.69 Million - $1.94 Million	11,657 Added 3.7%	326,793 $52.1 Million
Q4 2022 Feb 13, 2023	BUY	$138.31 - $165.87 $3.54 Million - $4.24 Million	25,579 Added 8.83%	315,136 $51 Million
Q3 2022 Nov 07, 2022	BUY	$134.21 - $153.93 $6.27 Million - $7.2 Million	46,747 Added 19.25%	289,557 $38.9 Million
Q2 2022 Aug 05, 2022	SELL	$137.62 - $174.96 $27,799 - $35,341	-202 Reduced 0.08%	242,810 $37.2 Million
Q1 2022 May 09, 2022	BUY	$131.98 - $163.75 $451,371 - $560,025	3,420 Added 1.43%	243,012 $39.4 Million
Q4 2021 Feb 07, 2022	SELL	$107.43 - $135.93 $788,213 - $997,318	-7,337 Reduced 2.97%	239,592 $32.4 Million
Q3 2021 Nov 04, 2021	SELL	$106.4 - $120.78 $307,921 - $349,537	-2,894 Reduced 1.16%	246,929 $26.6 Million
Q2 2021 Aug 05, 2021	SELL	$105.21 - $117.21 $121,201 - $135,025	-1,152 Reduced 0.46%	249,823 $28.1 Million
Q1 2021 May 05, 2021	SELL	$102.3 - $112.62 $488,687 - $537,985	-4,777 Reduced 1.87%	250,975 $27.2 Million
Q4 2020 Feb 08, 2021	SELL	$80.49 - $108.67 $3.31 Million - $4.47 Million	-41,143 Reduced 13.86%	255,752 $27.4 Million
Q3 2020 Nov 05, 2020	SELL	$85.91 - $100.83 $16.3 Million - $19.2 Million	-190,151 Reduced 39.04%	296,895 $26 Million
Q2 2020 Aug 05, 2020	BUY	$73.37 - $98.18 $2.7 Million - $3.61 Million	36,771 Added 8.17%	487,046 $47.8 Million
Q1 2020 May 01, 2020	BUY	$64.5 - $97.79 $247,357 - $375,024	3,835 Added 0.86%	450,275 $34.3 Million
Q4 2019 Feb 06, 2020	BUY	$72.13 - $90.25 $1.1 Million - $1.37 Million	15,194 Added 3.52%	446,440 $39.5 Million
Q3 2019 Nov 01, 2019	BUY	$62.98 - $75.72 $1.22 Million - $1.47 Million	19,410 Added 4.71%	431,246 $32.7 Million
Q2 2019 Aug 01, 2019	SELL	$65.7 - $83.98 $106,893 - $136,635	-1,627 Reduced 0.39%	411,836 $29.9 Million
Q1 2019 Apr 30, 2019	BUY	$77.14 - $90.79 $4.17 Million - $4.9 Million	54,022 Added 15.03%	413,463 $33.2 Million
Q4 2018 Feb 06, 2019	SELL	$77.85 - $96.01 $4.26 Million - $5.25 Million	-54,704 Reduced 13.21%	359,441 $33.1 Million
Q3 2018 Oct 29, 2018	SELL	$88.91 - $98.84 $4.4 Million - $4.89 Million	-49,456 Reduced 10.67%	414,145 $39.2 Million
Q2 2018 Jul 27, 2018	BUY	$89.78 - $106.23 $932,724 - $1.1 Million	10,389 Added 2.29%	463,601 $43 Million
Q1 2018 May 11, 2018	BUY	$92.01 - $123.21 $2.34 Million - $3.13 Million	25,396 Added 5.94%	453,212 $42.9 Million
Q4 2017 Jan 31, 2018	BUY	$89.56 - $98.21 $347,940 - $381,545	3,885 Added 0.92%	427,816 $41.4 Million
Q3 2017 Nov 02, 2017	BUY	$69.85 - $89.22 $29.6 Million - $37.8 Million	423,931	423,931 $37.7 Million

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cullen/Frost Bankers, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cullen/Frost Bankers, Inc. with notifications on news.

Account

Cullen/Frost Bankers, Inc. Abb Vie Inc. Transaction History